Intellia Therapeutics Inc buy Guggenheim
Start price
12.05.25
/
50%
€7.88
Target price
12.05.26
€40.09
Performance (%)
53.81%
Price
13.04.26
€12.12
Summary
This prediction is currently active. With a performance of 53.81% the BUY prediction by Guggenheim is a big success. This prediction currently runs until 12.05.26. The prediction end date can be changed by Guggenheim at any time. Guggenheim has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Intellia Therapeutics Inc | 6.503% | 6.503% |
| iShares Core DAX® | 3,02 % | 2,20 % |
| iShares Nasdaq 100 | 3,56 % | 1,33 % |
| iShares Nikkei 225® | 6,62 % | 5,71 % |
| iShares S&P 500 | 2,64 % | 1,01 % |
Comments by Guggenheim for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Guggenheim from $55.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat